🇮🇩@COVID19Up: More than 350 Indonesian healthcare workers, including doctors, have contracted COVID-19 despite being vaccinated with Sinovac. Dozens have already been hospitalized, officials said, as concerns rise about the efficacy of COVID-19 vaccines against more aggressive variants of SARS-CoV-2.
Designated as a priority group, Indonesian healthcare workers were among the first to be vaccinated in the country when the inoculation drive started in January.
Almost all Indonesian healthcare workers have received the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac, according to the Indonesian Medical Association.
“The data shows they have the Delta variant [in Kudus] so it is no surprise that the breakthrough infection is higher than before because as we know the majority of healthcare workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant,” said Dicky Budiman, an epidemiologist from Australia’s Griffith University.
— CNA (@ChannelNewsAsia) June 17, 2021
Several other countries that use Chinese vaccines have also been seeing rises in SARS-CoV-2 infections, prompting experts to reexamine the effectiveness of China’s COVID-19 vaccines.